To view this email as a web page, go here.

NewsWire Heading

A publication by ARDMS - The globally recognized standard of excellence in sonography - www.ARDMS.org
51 Monroe Street - Plaza East One - Rockville, MD 20850 - (800) 541-9754

Get connected with NewsWire! This bi-weekly e-newsletter from the American Registry for Diagnostic Medical Sonography® (ARDMS®), offers its Registrants and members of the sonography community current and innovative news and technology related to the field of sonography.

May 22, 2009

Headlines in the News:    

New Method to Watch and Measure Growing Biofilms with Ultrasound

Some kinds of bacteria can join forces to form protective communities called biofilms. These thin layers of bacteria, which grow on the surfaces of medical implants or directly on tissue in the body, can be difficult to treat because they are more resistant to drugs than the bacteria on their own. Currently there is no established way to image biofilms in or out of the body.

Pavlos Anastasiadis and colleagues at the University of Hawaii at Manoa have developed a method to watch and measure growing biofilms with ultrasound. The researchers used contrast agents, microparticles that are normally injected into the body to improve the quality of ultrasound images. They modified the surface of bubbles in the agents to stick to two kinds of infectious bacteria that form biofilms. Acoustic pulses of ultrasound cause the bubbles to "ring" like a bell, revealing their location and the attached biofilm.

The research was done on isolated biofilms. The next step will be to test it in living tissue. Anastasiadis hopes to develop the technique to diagnose infective endocarditis, a disease in which bacterial biofilms form on the inner walls of damaged heart valves.

View the article online.

Article written by staff at azonano.com and adapted for the purposes of this newsletter.

Back to Top

 

Ultrasound Images Take Aim at Cancer

Directing high-energy rays at cancer cells-and away from healthy ones-is a daunting challenge. Now consider that radiation therapy is sometimes being directed at a moving target.

Surgery to remove breast cancer, called a lumpectomy, is typically followed by a series of radiation treatments to help ensure that no cancer cells remain. Doctors use CT scans to help define the tumor cavity and its boundaries, but postsurgical bleeding and swelling may obscure the view. And small variations may translate to dramatic consequences.

A recent study shows that 90 percent of recurrent cases occur within about 1 inch of the tumor cavity. Another study reports that relying on the surgical scar to locate the radiation target often misses the mark.

"When delivering a radiation dose to the tumor bed it is imperative that the treatment plan is accurate," Dr. Janna Z. Andrews, Indiana University School of Medicine Assistant Professor of Radiation Oncology, Department of Radiation Oncology, explained to the Post. "Traditional CT scans generally offer the ability to visualize the tumor bed seroma (cavity). Then, a generous margin is added to ensure that the tumor bed is in the boost field."

Experts hope that an advanced ultrasound system from Resonant Medical may help target the treatment area with greater precision and minimize side effects from radiation therapy. The innovative equipment uses noninvasive sound waves to produce 3-D images.

Breast cancer patient Karen Mathis learned about the Clarity system while discussing treatment options with her physician, Dr. Joseph Imperato, who is director of radiation oncology at Lake Forest Hospital in Chicago where the specialized ultrasound unit was installed last year.

"I had heard that radiation can potentially damage other organs," said Mathis, who recently completed her recommended radiation treatments. "Breast tumors can be close to the heart and lungs. It was very reassuring to me to find out that Dr. Imperato uses the Clarity system to help target the cancer more precisely."

Dr. Imperato stresses that the evolving ultrasound technology is also cost-effective.

"This is more than a 'gee-whiz gizmo.' The addition of ultrasound as an adjunct to CT scanning provides a higher quality of care for the patient, and there is insurance reimbursement," he says. "A major benefit is the ability to feel very confident that you have localized the true lumpectomy cavity."

IU cancer specialist Dr. Andrews agrees that the Clarity system offers a unique alternative to target the tumor cavity.

"Using an ultrasound system for verification is an exciting advance because it offers the potential for better accuracy without increasing radiation exposure," she says. "With better accuracy, margins around the tumor bed may potentially be decreased, and more normal tissue can be spared from the toxicity of a higher radiation dose."

Additional follow-up data will reveal the long-term impact of using ultrasound to plan and deliver radiation treatments for cancer.

View the article online.

Article written by staff at saturdayeveningpost.com and adapted for the purposes of this newsletter.

Back to Top

 

Next-Gen Ultrasound

Almost invariably, a new baby's photo album begins with a grainy black-and-white picture taken months before birth-a ­prenatal ultrasound image, which is often detailed enough to inspire comments about the child's resemblance to various members of the family. But jokes about balding uncles notwithstanding, such scans serve a serious purpose and can prove immensely important, as when they allow doctors to diagnose and sometimes even repair a congenital malformation while the baby is still in the womb.

When seeing such an image for the first time, most people are awestruck. How can mere sound waves provide such remarkably clear views? Engineers may well ask something more: How can we give doctors even better ultrasound images? That question has engaged the three of us, along with other members of our Stanford acoustics group, for much of the last decade.

Whereas the signal-processing and image-reconstruction techniques used in medical sonography have made huge advances since this type of imaging became commonplace three decades ago, the business end of the apparatus-the transducer, which converts electrical impulses to sound waves and vice versa-has remained largely unchanged. So we found fertile ground when we began digging for ways to improve those transducers using tools from the microelectronics industry. You will soon find the fruits of those efforts at your local hospital. Indeed, this strategy promises to revolutionize ultrasound imaging within the next few years.

How ultrasound imaging works is easy enough to describe, at least in broad strokes. High-frequency (1- to 50-megahertz) sound waves transmitted into the body create reflections when they encounter a change in tissue density or stiffness. These faint echoes are picked up with the same set of transducers used to generate the sound. Or the imager may use just a single transducer moved over the body-usually with the aid of much slimy goo, to ensure good acoustic coupling. The resulting electrical signals are then amplified, combined, and displayed as images.

Sonography is valuable for several reasons. For one, it's inexpensive-at least compared with CT (computed tomography) and PET (positron-emission tomography) scanning, or with MRI (magnetic resonance imaging). Also, the low-amplitude ultrasound waves used for imaging do not involve ionizing radiation and are thus harmless to the patient, so repeated scans can be made without worry. And with this technique it is not difficult to get real-time imagery, which doctors may want for such things as guiding a biopsy needle. These virtues make the market for medical ultrasound equipment huge-more than US $5 billion annually, a figure that's only expected to swell in coming years with growing sales of these systems in China and India.

An ultrasound imager has four main parts: the transducer probe, the analog front-end electronics, the digital signal-processing hardware, and the display. Advances in electronics over the years have brought an extraordinary level of refinement to all but the transducer, which means that most of the remaining opportunities for improving system performance lie in the design of this one critical component. In particular, researchers have lately been seeking reliable ways to fashion many individual transducers into compact arrays.

Having a series of transducers laid out in a line-a one-dimensional array-is the simplest example of this strategy. Such transducer arrays are now employed routinely for most forms of ultrasound imaging. Like multielement radio antennas, such arrays can be steered so as to send energy in a narrow, directed beam. Steering an array also works in reverse, allowing it to detect acoustic echoes that come from one particular direction. While a one-­dimensional transducer array can be steered and focused within a single plane to make a two-­dimensional image, a 2D array can be steered and focused throughout a volume to make a three-­dimensional image-and this can be done in real time.

With this capability, physicians can, for example, follow heart motions in great detail if they want to assess a patient's cardiac functioning. In the not-so-distant future, such ultrasound imaging may even allow robotic surgeons to operate on a beating heart so that patients need not run the risk of having to depend on a heart-lung machine.

In the nearer term, doctors are keen to use small 2D arrays of tiny ultrasonic transducers to obtain forward-looking images as they probe an artery with a catheter. That would permit them to examine obstructions and map the composition of plaque deposits on vessel walls in three dimensions. What's more, sufficiently small transducers can be arranged in a ring on the end of a catheter, leaving space at the center for an excision device. Such an instrument would allow for simultaneous ultrasound imaging and surgical therapy.

Two-dimensional arrays of ultrasonic ­transducers would certainly help physicians perform mini­mally invasive treatments in this way. But making such tiny arrays using traditional transducers is frustratingly difficult. Fortunately, the precise fabrication required can readily be carried out using methods developed by the microelectronics industry, methods that are now routinely used to produce various sorts of microelectromechanical systems, or MEMS.

MEMS fabrication techniques have enabled us to construct something we call a capacitive micro­machined ultrasonic transducer. This name, we admit, is an ungainly mouthful, and the acronym we use in our scholarly papers, CMUT, is a bit cryptic to all but a few specialists. Perhaps this is why some of our colleagues in industry refer to this new technology by the more pleasing phrase "silicon ­ultrasound," which tells you right away what stuff these new transducers are for the most part made of.

View the article online.

Article written by staff at spectrum.ieee.org and adapted for the purposes of this newsletter.

Back to Top

 

Can Prenatal Ultrasound Detect the Effects of In-Utero Alcohol Exposure? A Pilot Study.

OBJECTIVES: The aim of this pilot study was to explore possible ultrasound parameters for the early detection of alcohol-mediated fetal somatic and central nervous system (CNS) maldevelopment. Maternal alcohol ingestion during pregnancy may lead to fetal alcohol spectrum disorders (FASD), which encompass a broad range of structural abnormalities including growth impairment, specific craniofacial features and CNS abnormalities. Early detection of fetuses at risk of FASD would support earlier interventions.

METHODS: We performed a longitudinal prospective pilot study from 2004 to 2006 at two sites in Ukraine. A sample of pregnant women who reported consuming moderate-to-heavy amounts of alcohol participated in a comprehensive maternal interview, and received ultrasound evaluation of fetal growth and specific fetal brain measurements during the second and third trimesters. These measurements were compared with those collected from a group of pregnant women who consumed little-to-no alcohol during pregnancy, and who were recruited and followed in the same manner.

RESULTS: From 6745 screened women, 84 moderate-to-heavy alcohol users and 82 comparison women were identified and ultrasound examinations performed. After controlling for maternal smoking, alcohol-exposed fetuses had shorter mean femur length, caval-calvarial distance and frontothalamic measurements in the second trimester (P less than 0.05), and alcohol-exposed fetuses also had shorter frontothalamic distance measurements in the third trimester relative to comparison fetuses (P less than 0.05). In addition, after controlling for maternal smoking, both mean orbital diameter and biparietal diameter measurements were significantly smaller on average in the alcohol-exposed group in the third trimester relative to comparison fetuses (P less than 0.05).

CONCLUSIONS: Significant differences in selected somatic and brain measurements were noted between alcohol-exposed and comparison fetuses, suggesting these markers may be further explored for clinical utility in prenatal identification of affected children. Further study correlating these findings with alcohol-related physical features of the newborn and subsequent comparisons of neuro-developmental outcomes will help define potential uses of prenatal ultrasound for intervention and prevention of FASD.

View the article online.

Article written by staff at cerebral-palsy-child.com and adapted for the purposes of this newsletter.

Back to Top

 

Ultrasound Useful in Predicting Thyroid Cancer Recurrence: Presented at AACE

For patients with thyroid cancer, ultrasound is an effective tool for long-term follow-up, according to a study presented here at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting and Clinical Congress on May 15.

Adrian M. Harvey, MD, University of Toronto, Toronto, Ontario, and colleagues retrospectively evaluated 191 patients with thyroid cancer to determine the usefulness of ultrasound in clinical follow-up.

Of the patients, 179 had differentiated thyroid cancer, and the others had medullary disease. To be included in the study, patients must have had at least 1 postsurgical ultrasound of the neck.

Based on existing criteria for sonography for malignant lymph nodes or thyroid bed recurrence, the researchers classified ultrasound findings as normal (N-US), suspicious (S-US), or equivocal (E-US).

They analyzed how expert-assessed ultrasound influenced the way other standard testing parameters, such as serum markers and fine-needle aspiration biopsy, were used and interpreted.

Between January 2000 and October 2008, 125 (32%) of 398 performed ultrasounds yielded abnormal findings. Of the 89 fine-needle aspiration biopsies performed, 59 (66%) were positive, 25 (28%) were negative, and 5 (6%) were equivocal.

Applying their classification scheme, the researchers determined that 85 ultrasounds were S-US and 40 were E-US. Disease recurrence took place in 78% of S-US but only 13% of E-US (P less than .01).

Subgroups were also analyzed on the basis of elevated tumor-marker detection. Tumor markers were elevated in 172 patients (43%), normal in 151 patients (38%), and equivocal in 75 patients (19%).

Seventy ultrasounds (41%) of the 172 patients positive for tumor markers were classified S-US; disease recurred in 61 (87%). Eighteen ultrasounds (11%) of the 172 were classified as E-US; disease recurred in 6 (33%). Also, the researchers found 15 S-US in patients with normal tumor-marker levels (disease recurrence in 67%) and 22 E-US in patients with equivocal tumor-marker status (disease recurrence in 5%).

Given that fine-needle aspiration biopsies from operated fields confirmed recurrent disease in 84% of S-US and 20% of E-US and that those from nonoperated fields did so in 70% of S-US and 9% of E-US, Dr. Harvey concluded that changes after surgery did not affect ultrasound accuracy.

The study found that classifying ultrasound findings as described herein, combined with tumor-marker status, helped to predict disease recurrence. Despite ultrasound's utility in patient follow-up, the researchers noted that tissue confirmation of recurrent disease is crucial before reoperating on the neck. Nevertheless, for the experienced clinician, operated fields do not prevent ultrasound from localizing recurrent cervical disease.

View the article online.

Article written by staff at docguide.com and adapted for the purposes of this newsletter.

Back to Top

 


question Want to say something, share something, change something?

Please e-mail all suggestions, questions and/or articles to communications@ardms.org, we look forward to hearing from you!

Back to Top

No longer want to receive ARDMS NewsWire?

Let us know and we'll remove you from the list.